ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease.

Lin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.